MedTrace Logo

Behavioral Medicine Intervention With Depressed Patients in a Community Health Center Setting

NCT01330420 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2017-11-21

Study results available
· View outcomes & findings →

Summary

The linkage between the Massachusetts General Hospital (MGH)-Community Health Associates and the MGH-Benson Henry Institute for Mind-Body Medicine began in order to address the concern of providing affordable, easily accessible, culturally appropriate behavioral medicine interventions for low income patients served by MGH Community Health Centers, as well as the desire to demonstrate the efficacy and economics of these interventions. Since depression was such a prevalent issue among health center patients, with a significant impact on health care service utilization, it was decided to focus on offering Mind/Body services to this population first.

Conditions

Interventions

BEHAVIORAL

Relaxation Response Resiliency Program for Depression

The program combines lecture, skills training, symptom monitoring, and group sharing aimed at preparing patients to take active roles in managing their own health. Elements of the program include: * Elicitation of the relaxation response through techniques such as diaphragmatic breathing and mindfulness. * Examination and reversal of negative thought patterns. * Physical movement, including stretching and yoga. * Healthy eating and other positive lifestyle behaviors. * Goal setting.

Sponsors & Collaborators

Principal Investigators

  • Gregory L. Fricchione, MD · Massachusetts General Hospital

  • Kathleen M. Miller, RN · Massachusetts General Hospital

  • Herbert Benson, MD · Massachusetts General Hospital

  • John W. Denninger, MD, PhD · Massachusetts General Hospital

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2010-04-30
Completion
2010-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01330420 on ClinicalTrials.gov